Main Article Content
Fetal Alcohol Spectrum Disorders (FASD), FASD 4-Digit Diagnostic Code
An interdisciplinary approach to fetal alcohol spectrum disorder (FASD) diagnosis using rigorously defined diagnostic guidelines has been adopted as best practice. Diagnostic clinics are being established worldwide. If these clinics are to successfully compete for limited health care dollars, it is essential to document their value.
The primary objectives were to document the value of the largest and longest standing interdisciplinary FASD diagnostic program; the Washington State Fetal Alcohol Syndrome Diagnostic & Prevention Network (WA FAS DPN). Now in its 17th year of operation, the WA FAS DPN is a statewide network of diagnostic clinics all using the 4-Digit Diagnostic Code and contributing to a centralized electronic database.
The clinical database was used to generate comprehensive profiles of all patients evaluated for FASD from 1993-2005. These profiles were used to answer a multitude of clinical, research, and public health questions including: What is the demand for FASD diagnostic services, who is referred to the clinics, and what are their FASD diagnostic outcomes? Can FAS/D prevalence estimates from this clinical population be used to estimate FAS/D prevalence estimates in the general population? Do FASD diagnostic outcomes vary by race, age or alcohol exposure? Does the presence of other adverse exposures/events lead to more severe outcomes? Does this approach to diagnosis meet the needs of families?
Demand for diagnosis remains very high. Of 1,400 patients (newborn to adult) with confirmed prenatal alcohol exposure, 11% were diagnosed with FAS/PFAS, 28% with static encephalopathy, 52% with neurobehavioral disorder, and 9% with no evidence of CNS abnormality. FASD outcomes varied significantly by age, race, gender, alcohol exposure, and presence of other risk factors. Families reported high satisfaction with the diagnostic process, and receipt of information/services they were unable to obtain elsewhere.
This report documents the immense contribution of a statewide FASD diagnostic program, and underscores the extraordinary value of a comprehensive FASD clinical dataset.
2. Astley S, Bailey D, Talbot T, Clarren S. Fetal alcohol syndrome (FAS) primary prevention through FAS diagnosis: I. Identification of highrisk birth mothers through the diagnosis of their children. Alcohol Alcohol. 2000;35(5):499-508.
3. Clarren S, Olson H, Clarren S, Astley S. A child with fetal alcohol syndrome. Baltimore: Paul H. Brookes Publishing Co; 2000.
4. Sokol R, Clarren S. Guidelines for use of terminology describing the impact of prenatal alcohol on the offspring. Alcohol Clin Exp Res. 1989;13:597-598.
5. Astley S, Clarren S. Diagnostic guide for fetal alcohol syndrome and related conditions: the 4- Digit Diagnostic Code. 2 ed. Seattle: University of Washington Publication Services; 1999.
6. Astley SJ. Diagnostic Guide for Fetal Alcohol Spectrum Disorders: The 4-Digit Diagnostic Code. 3rd ed. Seattle WA: University of Washington Publication Services; 2004.
7. Astley SJ, Clarren SK. Diagnosing the full spectrum of fetal alcohol exposed individuals: Introducing the 4-Digit Diagnostic Code. Alcohol Alcohol. 2000;35:400-410.
8. Astley SJ, Clarren SK. Diagnostic Guide to FAS and Related Conditions: The 4-Digit Diagnostic Code 1st ed. Seattle: University of Washington Publication Services; 1997.
9. Clarren S, Astley S. Development of the FAS Diagnostic and Prevention Network inWashington State. Seattle: University of Washington Press; 1997.
10. Astley SJ. Fetal Alcohol Syndrome Facial Photograph Analysis Software. In: Astley SJ, editor. 1.0 ed. Seattle: University of Washington; 2003.
11. Astley SJ, Clarren SK. Measuring the facial phenotype of individuals with prenatal alcohol exposure: correlations with brain dysfunction. Alcohol Alcohol. 2001;36:147-159.
12. Astley SJ, Clarren SK. A case definition and photographic screening tool for the facial phenotype of fetal alcohol syndrome. J Pediatr. 1996;129:33-41.
13. Astley S. Fetal alcohol syndrome prevention in Washingon State: Evidence of success. Paediatr Perinat Epidemiol. 2004;18:344-351.
14. Astley S, Stachowiak J, Clarren S, Clausen C. Application of the fetal alcohol syndrome facial photographic screening tool in a foster care population. J Pediatr. 2002;141(5):712-717.
15. Astley S. Interdisciplinary Approach to FASD Diagnosis using the FASD 4-Digit Diagnostic Code: Training Programs. [website] 2009 [cited 8/1/2009]; Available from: http://depts.washington.edu/fasdpn/htmls/training.h tm
16. Astley SJ, Aylward EH, Olson HC, et al. Magnetic resonance imaging outcomes from a comprehensive magnetic resonance study of children with fetal alcohol spectrum disorders. Alcohol Clin Exp Res. 2009;33(10):1-19.
17. Franklin L, Deitz J, Jirikowic T, Astley S. Children with fetal alcohol spectrum disorders: problem behaviors and sensory processing. Am J Occup Ther. 2008;62:265-273.
18. Olson HC, Jirikowic T, Kartin D, Astley SJ. Responding to the challenge of early intervention for fetal alcohol spectrum disorders. Infants and Young Children. 2007;20:172-189.
19. Coggins TE, Friet T, Morgan T. Analysing narrative productions in older school-age children and adolescents with fetal alcohol syndrome: an experimental tool for clinical applications Clinical Linguistics & Phonetics. 1998;12:221-236.
20. Bertrand J, Consortium F. Interventions for children with fetal alcohol spectrum disorders (FASDs): Overview of findings for five innovative research projects Res Dev Disabil. 2009;30(5):986- 1006.
21. Thorne J, Coggins T, Olson H, Astley S. Exploring the utility of narrative analysis in diagnostic decision making: picture-bound reference, elaboration, and fetal alcohol spectrum disorder. Journal of Speech, Language and Hearing Research. 2007;50:459-474.
22. Olswang L, Coggins T, Timler G. Outcome measures for school-age children with social communication problems. Topics in Language Disorders. 2001;22(1):50-73.
23. Astley SJ, Aylward EH, Olson HC, et al. Functional magnetic resonance imaging outcomes from a comprehensive magnetic resonance study of children with fetal alcohol spectrum disorders. Journal of Neurodevelopmental Disorders. 2009;1(1):61-80.
24. Astley SJ, Olson HC, Kerns K, et al. Neuropsychological and behavioral outcomes from a comprehensive magnetic resonance study of children with fetal alcohol spectrum disorders. Canadian Journal of Clinical Pharmacology. 2009;16(1):e178-e201.
25. Astley SJ, Richards T, Aylward EH, et al. Magnetic resonance spectroscopy outcomes from a comprehensive magnetic resonance study of children with fetal alcohol spectrum disorders. Magn Reson Imaging. 2009;27:760-778.
26. Bertrand J, Floyd RL, Weber MK, et al. National Task Force on FAS/FAE Fetal Alcohol Syndrome: Guidelines for Referral and Diagnosis: . Atlanta GA: Centers for Disease Control and Prevention 2004.
27. Chudley AE, Conroy J, Cook JL, Loock C, Rosales T, LeBlanc N. Public Health Agency of Canada’s National Advisory Committee on Fetal Alcohol Spectrum Disorder Fetal alcohol spectrum disorder: Canadian guidelines for diagnosis Can Med Assoc J. 2005;172:S1-S21.
28. ACCESS. Seattle:Microsoft Corp; 2000.
29. SPSS. Statistical Package for the Social Sciences. Chicago: IBMCompany; 2008.
30. Stratton K, Howe C, Battaglia F. Fetal Alcohol Syndrome: Diagnosis Epidemiology Prevention and Treatment. Institute of Medicine. Washington D C National Academy Press; 1996.
31. Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiol Community Health. 1990;1(1):43-46.
32. Bender R, Lange S. Adjusting for multiple testing-- when and how? J Clin Epidemiol. 2001;54(4):343- 349.
33. United States Census 2000. 2000 Available from: http://www.census.gov/census2000/states/wa.html
34. Achenbach T. Child Behavior Checklist (CBCL 6- 18) Burlington: University Associates in Psychiatry; 2001.
35. NIAAA. Seventh Special Report to the U.S. Congress on Alcohol and Health. Washington DC: US DHHS; 1990.
36. Denny C, Tsai J, Floyd R, Green P. Alcohol use among pregnant and non pregnant women of childbearing age--United States, 1991-2005. MMWR CDC Surveill Summ. 2009;58(19):529- 532.
37. Sampson PD, Streissguth A, Bookstein FL, et al. Incidence of fetal alcohol syndrome and prevalence of alcohol-related neurodevelopmental disorder. Teratology. 1997;56(5):317-326.
38. Sulik KK. Critical periods for alcohol teratogenesis in mice with special reference to the gastrulation stage of embyrogenesis. Mechanisms of Alcohol Damage in Utero. London Pitman Ciba Foundation Symposium; 1984. p. 124-141.
39. Astley S, Magnuson S, Omnell L, Clarren S. Fetal alcohol syndrome: change in craniofacial form wtih age, cognition, and timing of ethanol exposure in the macaque. Teratology. 1999;59(3): 163-172.
40. Wechsler D. WISC-III Manual San Antonio TX: Psychological Corporation 1996.
41. Beery KE. The Beery-Buktenica developmental test of visual-motor integration. 4th ed. Parsippany, NJ:Modern Curriculum Press; 1997.
42. Spreen O, Strauss E. A compendium of neuropsychological tests: Administration norms and commentary. 2nd ed. New York NY: Oxford University Press; 1998.
43. Black M, Matula K. Essentials of Bayley Scales of Infant Development II Assessment. New York: JohnWily; 1999.
44. Shaffer D, Fischer P, Lucas C, Comer J. Diagnostic Interview for Children (DISC-V). New York: Columbia University; 2003.
45. Mutti M, Sterling HM, Spalding N. Quick Neurological Screen Test. Novato CA: Academic Therapy Publications 1978.
46. Dunn W. Sensory Profile Manual. San Antonio: Psychological Corporation; 1999.